Spirepoint Private Client LLC Has $7.28 Million Stake in Procter & Gamble Company (The) $PG

Key Points

• Spirepoint Private Client LLC cut its Procter & Gamble stake by 44% in Q4, selling 39,955 shares and finishing the quarter with 50,768 shares valued at about $7.28 million, while institutional investors own roughly 65.77% of PG.
• Corporate insiders have been significant net sellers recently — 348,618 shares sold in the past 90 days (≈$55.46M), including Chairman Jon R. Moeller’s sale of 162,232 shares (~$26.35M).
• On fundamentals and sentiment, P&G reported Q2 EPS of $1.88 (beat by $0.02) with $22.21B revenue, pays a quarterly dividend of $1.0568 (2.9% yield), and has a consensus rating of "Moderate Buy" with a target near $164.26 amid mixed analyst price‑target revisions.

Spirepoint Private Client LLC decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 44.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,768 shares of the company's stock after selling 39,955 shares during the quarter. Spirepoint Private Client LLC's holdings in Procter & Gamble were worth $7,276,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Trilogy Capital Inc. grew its position in shares of Procter & Gamble by 1.1% during the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company's stock worth $901,000 after buying an additional 67 shares during the period. Emprise Bank grew its position in shares of Procter & Gamble by 2.5% during the 3rd quarter. Emprise Bank now owns 2,766 shares of the company's stock worth $425,000 after buying an additional 68 shares during the period. Affiance Financial LLC grew its position in shares of Procter & Gamble by 2.5% during the 3rd quarter. Affiance Financial LLC now owns 2,803 shares of the company's stock worth $431,000 after buying an additional 69 shares during the period. Beech Hill Advisors Inc. grew its position in shares of Procter & Gamble by 0.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 14,238 shares of the company's stock worth $2,040,000 after buying an additional 70 shares during the period. Finally, Dominguez Wealth Management Solutions Inc. grew its position in shares of Procter & Gamble by 0.3% during the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 20,464 shares of the company's stock worth $3,144,000 after buying an additional 71 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Stock Performance

Shares of PG stock opened at $146.69 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The company has a market capitalization of $340.90 billion, a P/E ratio of 21.73, a price-to-earnings-growth ratio of 5.10 and a beta of 0.41. The company's 50 day moving average price is $153.17 and its two-hundred day moving average price is $149.31. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $171.65.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business's quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the company posted $1.88 EPS. On average, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, January 23rd. Procter & Gamble's dividend payout ratio (DPR) is 62.52%.

Insider Activity

In other news, insider Susan Street Whaley sold 1,809 shares of Procter & Gamble stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $159.46, for a total value of $288,463.14. Following the sale, the insider directly owned 30,215 shares in the company, valued at $4,818,083.90. This trade represents a 5.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman owned 319,385 shares in the company, valued at $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 348,618 shares of company stock worth $55,462,643. Corporate insiders own 0.20% of the company's stock.

Analyst Upgrades and Downgrades

PG has been the subject of several analyst reports. JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a "neutral" rating to an "overweight" rating and lifted their price target for the stock from $157.00 to $165.00 in a research report on Friday, January 23rd. UBS Group reduced their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research note on Tuesday. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a research note on Friday, March 27th. Barclays set a $155.00 price objective on shares of Procter & Gamble in a research note on Friday, January 16th. Finally, BNP Paribas Exane reduced their price objective on shares of Procter & Gamble from $172.00 to $164.00 and set an "outperform" rating on the stock in a research note on Friday, January 16th. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $164.26.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: New product push — P&G launched "Mr. Clean PRO," a professional cleaning portfolio aimed at commercial customers; this expands addressable markets and can boost revenue durability in cleaning categories. P&G PRO Introduces Mr. Clean PRO
• Positive Sentiment: Brand relevance move — P&G struck a multi‑year, multi‑brand partnership with the WNBA to drive consumer engagement and younger/female audiences, which can support organic growth and marketing ROI. P&G WNBA Partnership Aims To Build Brand Relevance And Investor Interest
• Positive Sentiment: Positive media/strategy coverage — CNBC and other outlets highlighted P&G’s innovation strategy (what management calls its "lifeblood"), which can improve investor sentiment if investors see execution. The strategy P&G calls its 'lifeblood' and why it's key to the stock's turnaround
• Neutral Sentiment: Management succession in health care — P&G named a new health‑care CEO as a long‑time division leader retires; routine leadership changes can be neutral if transitions are smooth. P&G names new health care CEO as 33-year veteran retires
• Neutral Sentiment: Market commentary — Several outlets noted recent intraday moves (both gains and dips) and index tracking interest (Russell 1000), reflecting higher attention but not new fundamental data. Russell 1000 Index: Tracks Procter Gamble NYSE: PG Market Action Closely
• Negative Sentiment: Goldman Sachs trimmed its price target to $155 and kept a neutral rating — reduces upside in analyst consensus and likely weighs on near‑term sentiment. Goldman Sachs Adjusts PT on Procter & Gamble to $155
• Negative Sentiment: Multiple banks lowered targets — RBC cut its PT to $167 (keeps outperform), UBS cut to $166, Piper Sandler lowered to $142 (neutral), and Wells Fargo cut to $158 (still overweight). Collectively these trims reduce analyst upside and create selling pressure. RBC Cuts Price Target on Procter & Gamble to $167 UBS Lowers Procter & Gamble Price Target to $166 Piper Sandler Adjusts PT on Procter & Gamble to $142 Wells Fargo Adjusts PT on Procter & Gamble to $158
• Negative Sentiment: Analyst downgrade impact — Coverage notes the stock moved lower after recent downgrades, illustrating how sentiment shifts among major brokers are driving short‑term volatility. Procter & Gamble Stock Price Down 1.1% After Analyst Downgrade

About Procter & Gamble

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.